Cargando…

HDL, Atherosclerosis, and Emerging Therapies

This review aims to provide an overview on the properties of high-density lipoproteins (HDLs) and their cardioprotective effects. Emergent HDL therapies will be presented in the context of the current understanding of HDL function, metabolism, and protective antiatherosclerotic properties. The epide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hafiane, Anouar, Genest, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678415/ https://www.ncbi.nlm.nih.gov/pubmed/23781332 http://dx.doi.org/10.1155/2013/891403

Ejemplares similares

High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk
por: Hafiane, Anouar, et al.
Publicado: (2015)

Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro
por: Hafiane, Anouar, et al.
Publicado: (2015)

Vulnerable Plaque, Characteristics, Detection, and Potential Therapies
por: Hafiane, Anouar
Publicado: (2019)

SARS-CoV-2 and the cardiovascular system
por: Hafiane, Anouar
Publicado: (2020)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
por: Valanti, Eftaxia-Konstantina, et al.
Publicado: (2018)

HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis
por: Borja, Mark S., et al.
Publicado: (2013)

HDL signaling and protection against coronary artery atherosclerosis in mice
por: Trigatti, Bernardo L, et al.
Publicado: (2016)

Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
por: Vyletelová, Veronika, et al.
Publicado: (2022)

Simultaneous Noninvasive Detection and Therapy of Atherosclerosis Using HDL Coated Gold Nanorods
por: Ankri, Rinat, et al.
Publicado: (2022)

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2021)

Identification of Docetaxel as a Potential Drug to Promote HDL Biogenesis
por: Choi, Hong Y., et al.
Publicado: (2021)

Emerging therapeutic strategies to enhance HDL function
por: Redondo, Santiago, et al.
Publicado: (2011)

Measures of high-density lipoprotein function in men and women with severe aortic stenosis
por: Hafiane, Anouar, et al.
Publicado: (2022)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015)

Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality?
por: Holme, Siri A. N., et al.
Publicado: (2020)

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
por: Hafiane, Anouar, et al.
Publicado: (2022)

Beyond Statins: Emerging Evidence for HDL-Increasing Therapies and Diet in Treating Cardiovascular Disease
por: Farrer, Sterling
Publicado: (2018)

The LDL-HDL Profile Determines the Risk of Atherosclerosis: A Mathematical Model
por: Hao, Wenrui, et al.
Publicado: (2014)

TG/HDL Ratio: A marker for insulin resistance and atherosclerosis in prediabetics or not?
por: Chauhan, Ajay, et al.
Publicado: (2021)

Very low levels of HDL cholesterol and atherosclerosis, a variable relationship – a review of LCAT deficiency
por: Savel, Julia, et al.
Publicado: (2012)

HDL Size is More Accurate than HDL Cholesterol to Predict Carotid Subclinical Atherosclerosis in Individuals Classified as Low Cardiovascular Risk
por: Parra, Eliane Soler, et al.
Publicado: (2014)

The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality
por: Cho, Kyung-Hyun
Publicado: (2022)

Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies
por: Marsche, Gunther, et al.
Publicado: (2022)

Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults
por: Kelesidis, Theodoros, et al.
Publicado: (2013)

Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation
por: Rein, Philipp, et al.
Publicado: (2010)

Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
por: Morin, Emily E., et al.
Publicado: (2020)

Triglyceride/HDL-Cholesterol Ratio as an Index of Intracranial Atherosclerosis in Nonstroke Individuals
por: Woo, Min-Hee, et al.
Publicado: (2021)

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
por: Srivastava, Neelam, et al.
Publicado: (2018)

Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice
por: Ishikawa, Kazunobu, et al.
Publicado: (2012)

P2Y13 Receptor Regulates HDL Metabolism and Atherosclerosis In Vivo
por: Goffinet, Marine, et al.
Publicado: (2014)

Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
por: Schoch, Leonie, et al.
Publicado: (2021)

Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL
por: Cao, Peiqiu, et al.
Publicado: (2015)

HDL-Based Therapy: Vascular Protection at All Stages
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Levels of Cholesterol in Small LDL Particles Predict Atherosclerosis Progression and Incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)
por: Williams, Paul T., et al.
Publicado: (2013)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Chernick, Dustin, et al.
Publicado: (2020)

Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism
por: Xu, Yanyong, et al.
Publicado: (2021)

Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis
por: Zhou, Mei, et al.
Publicado: (2019)

HDL endocytosis and resecretion()
por: Röhrl, Clemens, et al.
Publicado: (2013)

HDL Is Not Dead Yet
por: Lorkowski, Shuhui Wang, et al.
Publicado: (2022)

HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?
por: Karalis, I., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vu113037dh38mk6kltp41n8pg0